Watch how in-line IV filters retain particles

Dr Volker Luibl

Sr. Marketing Manager Medical Content | Pall Medical, part of Cytiva

IV Filtration

Everyday, millions of inadvertent particles may be infused into patients during hospitalization, especially in intensive care units, and are likely to worsen the pathogenetic effect in vulnerable patients.^1,2

We make the invisible visible and challenged our Posidyne™ in-line IV filters with 100 µm polystyrene red labeled particles. Watch this video and see how our in-line IV filters retain the particles.

Watch this video: How in-line IV filters retain particles

^{This video is a non‑clinical demonstration for illustrative purposes only and does not represent validated Pall product performance, clinical outcomes, or conditions of use; users must refer to the device Instructions for Use for approved indications and limitations.}

Explore our IV particle retention solutions

References

Perez M, Décaudin B, Chahla WA, Nelken B, Barthélémy C, Lebuffe G, et al. In vitro analysis of overall particulate contamination exposure during multidrug IV therapy: impact of infusion sets. Pediatr Blood Cancer. 2015;62(6):1042-1047. doi:10.1002/pbc.25442.
Perez M, Maigyu-Foinard A, Barthélémy C, Décaudin B, Odou P. Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients. Pharm Technol Hosp Pharm. 2016;1(2):91-103. doi.org.10.1515/pthp-2016-0004.